CDEK
← All organizations

Vistakon Pharmaceuticals

For profitContributed to NME

Also known as: Vistakon Pharmaceutical

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2005

First marketed drug

Jul 28, 2010

First NDA

Jul 28, 2010

Last known activity

Oct 1, 2009

Acquired by Johnson and Johnson on Jun 1, 1981

Timeline

1950s

  1. Jun 1, 1959

    Vistakon Pharmaceuticals— Founded

1980s

  1. Jun 1, 1981

    Johnson and Johnson— Acquired By

2010s

  1. Jul 28, 2010

    alcaftadine— NDA Organization

Drugs by trial phase (6 distinct, 11 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Recent trials (14)

Details

Founded
Buffalo, NY, US Jun 1, 1959
First NDA
Jul 28, 2010
Last known activity
Oct 1, 2009